LINC01089 ngăn chặn sự tiến triển ác tính của ung thư tuyến giáp bằng cách gắn kết với miR-27b-3p để tăng cường nồng độ protein FBLN5
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kim J, Gosnell JE, Roman SA. Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol. 2020;16:17–29.
Song E, Jeon MJ, Oh HS, Han M, Lee YM, Kim TY, Chung KW, Kim WB, Shong YK, Song DE, Kim WG. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma? Eur J Endocrinol. 2018;179:135–42.
Albano D, Panarotto MB, Durmo R, Rodella C, Bertagna F, Giubbini R. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer. Endocrine. 2019;63:79–86.
Albano D, Bertagna F, Bonacina M, Durmo R, Cerudelli E, Gazzilli M, Panarotto MB, Formenti AM, Mazziotti G, Giustina A, Giubbini R. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines. Eur J Endocrinol. 2018;179:143–51.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.
Ye M, Dong S, Hou H, Zhang T, Shen M. Oncogenic role of long noncoding RNAMALAT1 in thyroid cancer progression through regulation of the miR-204/IGF2BP2/m6A-MYC signaling. Mol Ther Nucleic Acids. 2021;23:1–12.
Li Q, Chen W, Luo R, Zhang Z, Song M, Chen W, Yang Z, Yang Y, Guo Z, Yang A. Upregulation of OIP5-AS1 predicts poor prognosis and contributes to thyroid cancer cell proliferation and migration. Mol Ther Nucleic Acids. 2020;20:279–91.
Peng D, Li W, Zhang B, Liu X. Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy. J Cell Mol Med. 2021;25:8148–58.
Jiang B, Chen Y, Xia F, Li X. PTCSC3-mediated glycolysis suppresses thyroid cancer progression via interfering with PGK1 degradation. J Cell Mol Med. 2021;25:8454–63.
Li M, Guo X. LINC01089 blocks the proliferation and metastasis of colorectal cancer cells via regulating miR-27b-3p/HOXA10 Axis. Onco Targets Ther. 2020;13:8251–60.
Yuan H, Qin Y, Zeng B, Feng Y, Li Y, Xiang T, Ren G. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer. Onco Targets Ther. 2019;12:4883–95.
Zhang D, Cai X, Cai S, Chen W, Hu C. Long intergenic non-protein coding RNA 01089 weakens tumor proliferation, migration, and invasion by sponging miR-3187-3p in non-small cell lung Cancer. Cancer Manage Res. 2020;12:12151–62.
Sun J, Zheng X, Wang B, Cai Y, Zheng L, Hu L, Lu X, Xie S, Zhang X, Liu H, Ye L. LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells. Acta Biochim Biophys Sin (Shanghai). 2022;54:261–70.
Guo X, Li M. LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p/TET1 axis. Cancer Cell Int. 2020;20:507.
Chen B, Liu D, Chen R, Guo L, Ran J. Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression. Discov Oncol. 2022;13:56.
Yi D, Zhang D, Zeng Z, Zhang S, Li M, Zhang Y. MicroRNA-144–3p represses the growth and EMT of thyroid cancer via the E2F2/TNIK axis in cells and male BALB/c nude mice. Endocrinology. 2022;163:bqac071.
Fontanil T, Mohamedi Y, Cobo T, Cal S, Obaya ÁJ. Novel associations within the tumor microenvironment: fibulins meet ADAMTSs. Front Oncol. 2019;9:796.
Zheng L, Yue X, Li M, Hu J, Zhang B, Zhang R, Zheng G, Chen R, Dong H. Contribution of FBLN5 to unstable plaques in carotid atherosclerosis via mir128 and mir532-3p based on bioinformatics prediction and validation. Front Genet. 2022;13:821650.
Mohamedi Y, Fontanil T, Solares L, Garcia-Suárez O, García-Piqueras J, Vega JA, Cal S, Obaya AJ. Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells. Int J Oncol. 2016;48:1447–56.
Li Y, Yang X, Lu D. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5). Bioengineered. 2022;13:11867–80.
Huang M, Liao X, Li L, Li G, Chen M. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway. Tissue Cell. 2021;73:101672.
Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92-97.
Wong NW, Chen Y, Chen S, Wang X. OncomiR: an online resource for exploring pan-cancer microRNA dysregulation. Bioinformatics. 2018;34:713–5.
Bao CH, Guo L. miR-27b-3p inhibits invasion, migration and epithelial-mesenchymal transition in gastric cancer by targeting RUNX1 and activation of the Hippo Signaling Pathway. Anticancer Agents Med Chem. 2021. https://doi.org/10.2174/1871520621666210707095833.
Han M, Li N, Li F, Wang H, Ma L. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2. Hum Cell. 2020;33:641–51.
Liu L, Hu J, Yu T, You S, Zhang Y, Hu L. miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway. Acta Biochim Biophys Sin (Shanghai). 2019;51:492–500.
Shen SJ, Song Y, Ren XY, Xu YL, Zhou YD, Liang ZY, Sun Q. MicroRNA-27b-3p promotes tumor progression and metastasis by inhibiting peroxisome proliferator-activated receptor gamma in triple-negative breast cancer. Front Oncol. 2020;10:1371.
Yang X, Chen J, Liao Y, Huang L, Wen C, Lin M, Li W, Zhu Y, Wu X, Iwamoto A, Wang Z, Liu H. MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. Biosci Rep. 2019;39:BSR20191087.
Xu Y, Han YF, Ye B, Zhang YL, Dong JD, Zhu SJ, Chen J. miR-27b-3p is involved in doxorubicin resistance of human anaplastic thyroid cancer cells via targeting peroxisome proliferator-activated receptor gamma. Basic Clin Pharmacol Toxicol. 2018;123:670–7.
Li M, Tian X, Guo H, Xu X, Liu Y, Hao X, Fei H. A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer. Braz J Med Biol Res. 2021;54: e11592.
Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, Müller M, Schulz WA. Downregulation of several fibulin genes in prostate cancer. Prostate. 2007;67:1770–80.
Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 2006;66:2621–9.
Heo JH, Song JY, Jeong JY, Kim G, Kim TH, Kang H, Kwon AY, An HJ. Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer. J Clin Pathol. 2016;69:109–16.
Mao J, Wang L, Wu J, Wang Y, Wen H, Zhu X, Wang B, Yang H. miR-370-3p as a novel biomarker promotes breast cancer progression by targeting FBLN5. Stem Cells Int. 2021;2021:4649890.
Li R, Wu H, Jiang H, Wang Q, Dou Z, Ma H, Yan S, Yuan C, Yang N, Kong B. FBLN5 is targeted by microRNA-27a-3p and suppresses tumorigenesis and progression in high-grade serous ovarian carcinoma. Oncol Rep. 2020;44:2143–51.